{"id":"butacetin","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"tromal","offLabel":[],"synonyms":["BW 63-90","butacetin","tromal"],"timeline":[],"brandName":"Tromal","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's pain and inflammation response like a fire. Prostaglandins are like the fuel that keeps the fire burning. Tromal works by reducing the amount of fuel available, thereby reducing the pain and inflammation.","oneSentence":"Tromal is thought to work by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain and inflammation.","technicalDetail":"Tromal is believed to exert its effects through the inhibition of cyclooxygenase enzymes, specifically COX-1 and COX-2, which are responsible for the conversion of arachidonic acid to prostaglandins."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3690","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=butacetin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:06:02.429611","biosimilars":[],"competitors":[],"genericName":"butacetin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"2487QE5LU9","CHEBI":"CHEBI:134873","UMLSCUI":"C4684938","ChEMBL_ID":"CHEMBL2104218","KEGG_DRUG":"D03181","PUBCHEM_CID":"16426"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Pain"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Tromal (butacetin) is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. The approved indications for Tromal are also unknown. As a small molecule, Tromal is likely to be administered orally, but its pharmacokinetic properties, such as half-life and bioavailability, are not well-documented. Further research is needed to fully understand the clinical profile of Tromal.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}